Skip to main content
. 2018 Nov;26(11):1461–1473. doi: 10.1016/j.joca.2018.07.013
Total No KP (Q11) Knee pain (Q11) P-value
N 9506 5218 4288
Conditions
High cholesterol, n (%) 2634 (27.71) 1356 (26.00) 1278 (29.80) <0.0001
Heart attack/angina, n (%) 604 (6.35) 287 (5.50) 317 (7.39) 0.0002
Hypertension, n (%) 2845 (29.93) 1400 (26.85) 1445 (33.70) <0.0001
Diabetes, n (%) 899 (9.46) 423 (8.11) 476 (11.10) <0.0001
Underactive/overactive thyroid, thyroiditis, n (%) 369 (3.88) 185 (3.54) 184 (4.29) 0.0608
Stroke, n (%) 271 (2.85) 142 (2.72) 129 (3.01) 0.4045
Multiple sclerosis, n (%) 18 (0.19) 10 (0.19) 8 (0.19) 0.9551
Irritable bowel syndrome, n (%) 963 (10.13) 427 (8.19) 536 (12.50) <0.0001
Fibromyalgia, n (%) 246 (2.59) 68 (1.30) 178 (4.15) <0.0001
Chronic fatigue syndrome, n (%) 133 (1.40) 55 (1.05) 78 (1.82) 0.0016
Chronic obstructive pulmonary disease (COPD), n (%) 103 (1.08) 54 (1.03) 49 (1.14) 0.6126
Asthma, n (%) 412 (4.33) 212 (4.06) 200 (4.66) 0.1514
Idiopathic pulmonary fibrosis, n (%) 3 (0.03) 3 (0.06) 0 (0.00) 0.1164
Liver cirrhosis, n (%) 6 (0.06) 4 (0.08) 2 (0.05) 0.5622
Hepatitis, n (%) 5 (0.05) 2 (0.04) 3 (0.07) 0.5031
Non-alcoholic fatty liver disease, n (%) 6 (0.06) 4 (0.08) 2 (0.05) 0.5622
Rheumatoid arthritis, n (%) 92 (0.97) 25 (0.48) 67 (1.56) <0.0001
Ankylosing spondylitis, n (%) 19 (0.20) 3 (0.06) 16 (0.37) 0.0006
Lupus, n (%) 12 (0.13) 4 (0.08) 8 (0.19) 0.1331
Psoriatic arthritis, n (%) 17 (0.18) 4 (0.08) 13 (0.30) 0.0093
Systems affected
Cardiovascular disease, n (%) 4124 (43.38) 2105 (40.34) 2019 (47.08) <0.0001
Endocrine disease, n (%) 1229 (12.93) 595 (11.40) 634 (14.79) <0.0001
Non-restorative pain disorders, n (%) 1164 (12.24) 497 (9.52) 667 (15.56) <0.0001
Lung disease, n (%) 497 (5.23) 263 (5.04) 234 (5.46) 0.3624
Liver disease, n (%) 17 (0.18) 10 (0.19) 7 (0.16) 0.7447
Chronic kidney disease/failure (CKD), n (%) 23 (0.24) 8 (0.15) 15 (0.35) 0.0523
Central nervous system disorders, n (%) 289 (3.04) 152 (2.91) 137 (3.19) 0.4246
Gout, n (%) 94 (0.99) 54 (1.03) 40 (0.93) 0.6175
Chronic rheumatic conditions, n (%) 138 (1.45) 35 (0.67) 103 (2.40) <0.0001
Comorbidity count
N of comorbidities, mean (SD), n (%) 0.80 (0.85) 0.71 (0.81) 0.90 (0.90) <0.0001
Any comorbidities, n (%) 5355 (56.33) 2740 (52.51) 2615 (60.98) <0.0001
Any comorbidities ≥ 2, n (%) 1804 (18.98) 822 (15.75) 982 (22.90) <0.0001
Any comorbidities ≥ 3, n (%) 367 (3.86) 137 (2.63) 230 (5.36) <0.0001
Any comorbidities ≥ 4, n (%) 45 (0.47) 19 (0.36) 26 (0.61) 0.0868